JRCT ID: jRCT2052210134
Registered date:17/12/2021
Clinical Trial of POD T 49P
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | Cataract |
Date of first enrollment | 17/12/2021 |
Target sample size | 56 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Perform cataract surgery and implant an intraocular lens; POD T 49P in the aphakic eye. |
Outcome(s)
Primary Outcome | Uncorrected visual acuity at Visit 4 Manifest Cylinder power at Visit 4 |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | - Subject with corneal astigmatism - Target postoperative refraction is emmetropia |
Exclude criteria | - Subjects with diseases that affect postoperative visual acuity in the cornea or retina - Irregular corneal aberration - Poor mydriasis - Previous refractive surgery - Other protocol-defined exclusion criteria may apply. |
Related Information
Primary Sponsor | Miyajima Bissen Hiroko |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Tsunemitsu Senta |
Address | 2-8 Kojimachi, Chiyoda-ku, Tokyo Tokyo Japan 102-0083 |
Telephone | +81-3-5214-2277 |
tsenta@bvimedical.com | |
Affiliation | BVI Japan |
Scientific contact | |
Name | Hiroko Bissen Miyajima |
Address | 2-9-18 Kanda-Misakicho, Chiyoda-ku, Tokyo Tokyo Japan 101-0061 |
Telephone | +81-3-5275-1856 |
bissen@tdc.ac.jp | |
Affiliation | Tokyo Dental College Suidobashi Hospital |